Appeal No. 1998-2010
Application No. 08/542,861
or defined groupings of claims. For our part, we have considered the claims separately,
including the composition and method claims. 37 CFR §1.192(c)(7) (1996).
Background
The subject matter of the present claims relates to compounds which act as
inhibitors of retroviral protease. Claims 1, 17 and 27. The claimed invention also
encompasses pharmaceutical compositions (e.g., claim 5); methods of inhibiting retroviral
protease (e.g., claim 7); methods of treating retroviral infection (e.g., claim 9); and
methods of treating AIDS (e.g., claim 11).
DISCUSSION
In reaching our decision in this appeal, we have given consideration to the
appellants’ specification and claims, to the applied reference, and to the respective
positions articulated by the appellants and the examiner.
Rather than reiterate the conflicting viewpoints advanced by the examiner and the
appellants regarding the noted rejections, we make reference to the examiner's Answer for
the examiner's reasoning in support of the rejection, and to the appellants’ Brief for the
appellants’ arguments thereagainst. As a consequence of our review, we make the
determinations which follow.
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007